Germany to scrap plan to lower prices of new drugs-lawmakers

Yahoo Finance

6 March 2017 - Germany's ruling coalition will scrap plans announced last year to lower prices of newly launched drugs within the first 12 months should sales exceed 250 million euros ($264.83 million), lawmakers told Reuters on Monday.

Germany, Europe's biggest market for medicines, said in July it wanted to extend a price brake for drugs covered by statutory health insurance for five years beyond 2017, stretching out the measure introduced in 2009.

This so-called 'price moratorium' will be extended as originally planned, lawmakers from Chancellor Angela Merkel's ruling coalition said.

Read Yahoo Finance article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Germany